Docusate Sodium
- Product NDC
- 16103-399
- 11-digit product format
- 161030399
- Labeler code
- 16103
- Product ID
- 16103-399_43b71fc6-6af3-4f45-a946-ab9cff49f5ba
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docusate Sodium 100mg
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Pharbest Pharmaceuticals, Inc.
- Application
- M
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2016-03-01
- Substance
- DOCUSATE SODIUM
- Active strength
- 100 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 16103-399-11 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 16103-399-08 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 16103-399-11 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 16103-399-08 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 16103-399-11 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 16103-399-08 | bd6a592717d7… | 303034d00443… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Docusate Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 100 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F05Q2T2JA0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1115005 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 025e03e0-e273-47ed-87f7-98e388abe047 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3c386306-c48a-413e-bb69-70cb268496f3 | Product name | 1 | 20210727 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 16103-399-08 | 2026-01-29 | Docusate Sodium 100 mg Softgels |
| 16103-399-11 | 2026-01-29 | Docusate Sodium 100 mg Softgels |
| 16103-399-08 | 2024-01-19 | Docusate Sodium 100 mg Softgels |
| 16103-399-11 | 2024-01-19 | Docusate Sodium 100 mg Softgels |
| 16103-399-08 | 2022-01-28 | Docusate Sodium 100 mg Softgels |
| 16103-399-11 | 2022-01-28 | Docusate Sodium 100 mg Softgels |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16103-399-08 | Docusate Sodium | 100 in 1 BOTTLE | CAPSULE | 100 | 3 | |
| 16103-399-11 | Docusate Sodium | 1000 in 1 BOTTLE | CAPSULE | 1000 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16103-399-08 | EA - Each | 16103-399 | 463d6a62-9936-4856-91dd-fe23717ceae5 | 1 | 2019-04-11 |
| 16103-399-11 | EA - Each | 16103-399 | 0cad9fe1-9128-4221-bb7b-c73e708258bb | 1 | 2019-04-11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Menthol Pain Relieving Cream with Menthol 10% | MENTHOL 10% CREAM | ONE2ZEE LIMITED LIABILITY COMPANY | ae09e93f-3988-4477-ae53-b2f3df9769fb | 2025-05-05 | Warnings | M |
| Anua Zero-Cast Moisturizing Finish Sunscreen SPF 50 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | ENGLEWOOD LAB, INC. | edf07b7f-46fb-4915-b2ea-83d852617f60 | 2025-04-10 | Warnings | M |
| BRONCOCHEM KIDS COLD AND FLU | ACETAMINOPHEN-PHENYLEPHRINE HCL-GUAIFENESIN | LABORATORIO MAGNACHEM INTERNATIONAL SRL | b6559fb9-2dea-49c0-a274-3e77741a0ffd | 2025-03-23 | Warnings | M |
| BRONCOCHEM MAXIMUM COUGH | DEXTROMETHORPHAN HBR-GYAIFENESIN | LABORATORIO MAGNACHEM INTERNATIONAL SRL | deecdb72-4cdb-4d6f-972f-a425a91afa5a | 2025-03-23 | Warnings | M |
| BRONCOCHEM MAXIMUM COUGH NIGHT | DEXTROMETHORPHAN HBR-PYRILAMINE MALEATE | LABORATORIO MAGNACHEM INTERNATIONAL SRL | dffdfa2c-a52e-4606-9b07-c8993e499f09 | 2025-03-23 | Warnings | M |
| BRONCOCHEM EXPECTORANT II | ACETAMINOPHEN-CHLORPHENIRAMINE MALEATE-DEXTROMETHORPHAN HBR-GUAIFENESIN-PHENYLEPHRINE HCL | LABORATORIO MAGNACHEM INTERNATIONAL SRL | 1fb86dcb-6f51-4c29-99ad-a5a9b7b7526a | 2025-03-23 | Warnings | M |
| BRONCOCHEM MAXIMUM COUGH KIDS | DEXTROMETHORPHAN HBR-GUAIFENESIN | LABORATORIO MAGNACHEM INTERNATIONAL SRL | b0fd2f2f-5cc4-4813-8f99-c78fbe898656 | 2025-03-13 | Warnings | M |
| Menthol Pain Relief Gel Patch | MENTHOL PAIN RELIEF GEL PATCH | ONE2ZEE LIMITED LIABILITY COMPANY | eab185d6-2a54-489d-8114-fe8088624ba4 | 2025-03-04 | Warnings | M |
| Lidocaine 4% Pain Relief Gel Patch | LIDOCAINE 4% PAIN RELIEF GEL PATCH | ONE2ZEE LIMITED LIABILITY COMPANY | 8e5a4ef4-b928-44b3-842c-92f1531af75b | 2025-03-03 | Warnings | M |
| gas relief | SIMETHICONE | Strategic Sourcing Services LLC | 23005295-c5f2-4a76-8431-4a9b8d817d4d | 2025-01-03 | Warnings | M |
| Foster and Thrive infants Gas relief | SIMETHICONE | Strategic Sourcing Services LLC | 824c9dff-0a26-4710-a25b-39df631d6fa6 | 2024-12-13 | Warnings | M |
| BRONCOCHEM COLD AND FLU TEA | ACETAMINOPHEN-PHENYLEPHRINE HYDROCHLORIDE-CHLORPHENIRAMINE MALEATE | LABORATORIO MAGNACHEM INTERNATIONAL SRL | b7d3f54e-59ef-4b85-a88d-b053058dc1f6 | 2024-12-12 | Warnings | M |
| HYSAN PAIN RELIEVER | METHYL SALICYLATE, CAMPHOR (SYNTHETIC) | HYSAN PHARMACEUTICAL CO LTD | bad73234-c204-40a8-8176-45c75ae500c8 | 2024-10-07 | Warnings | M |
| HYSAN ANALGESIC | METHYL SALICYLATE, CAMPHOR (SYNTHETIC) | HYSAN PHARMACEUTICAL CO LTD | 99a13b0a-1d77-479e-ba99-2cfa638de339 | 2024-10-04 | Warnings | M |
| HYSAN HUO LU MEDICATED | METHYL SALICYLATE, CAMPHOR (SYNTHETIC) | HYSAN PHARMACEUTICAL CO LTD | fe9eeaff-fcbf-4287-9f17-bcf1822bf35b | 2024-10-04 | Warnings | M |
| HYSAN HUA TUO MEDICATED | METHYL SALICYLATE | HYSAN PHARMACEUTICAL CO LTD | b84c4d33-5a77-46e0-b04e-32f73967bd1c | 2024-10-04 | Warnings | M |
| HYSAN HUA TUO HUO LU | METHYL SALICYLATE, CAMPHOR (SYNTHETIC) | HYSAN PHARMACEUTICAL CO LTD | cd2288c4-9909-43c1-91da-b15545b09788 | 2024-10-04 | Warnings | M |
| CLARINS - ROLL-ON DEODORANT Aluminum Chlorohydrate - Antiperspirant, Long-lasting Alcohol-free | ALUMINUM CHLOROHYDRATE | Laboratoires Clarins | 412116a1-f9af-4c03-85e0-aad5738dd797 | 2024-08-05 | Warnings | M |
| BRONCOCHEM MAXIMUM COUGH NIGHT | DEXTROMETHORPHAN HBR-PYRILAMINE MALEATE | LABORATORIO MAGNACHEM INTERNATIONAL SRL | 1a3ed214-e09b-4266-b68b-39e7c3127d26 | 2024-04-22 | Warnings | M |
| CLARUS Antifungal | TOLNAFTATE | Clinical Therapeutic Solutions | 835c3c23-fc3c-404e-8e87-5a0176126730 | 2024-02-28 | Warnings | M |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1115005 | docusate sodium 100 MG Oral Capsule | PSN | 66ca7a94-378b-4476-8060-d9c6f82f57fc | 19 |
| 1115005 | docusate sodium 100 MG Oral Capsule | SCD | 66ca7a94-378b-4476-8060-d9c6f82f57fc | 19 |
| 1115005 | DOSS Sodium 100 MG Oral Capsule | SY | 66ca7a94-378b-4476-8060-d9c6f82f57fc | 19 |
| 1115005 | docusate sodium 100 MG Oral Capsule | PSN | 025e03e0-e273-47ed-87f7-98e388abe047 | 3 |
| 1115005 | docusate sodium 100 MG Oral Capsule | SCD | 025e03e0-e273-47ed-87f7-98e388abe047 | 3 |
| 1115005 | DOSS Sodium 100 MG Oral Capsule | SY | 025e03e0-e273-47ed-87f7-98e388abe047 | 3 |
| 1115005 | docusate sodium 100 MG Oral Capsule | PSN | 1b2f2afd-1e8a-058c-e063-6294a90a24ff | 2 |
| 1115005 | docusate sodium 100 MG Oral Capsule | SCD | 1b2f2afd-1e8a-058c-e063-6294a90a24ff | 2 |
| 1115005 | DOSS Sodium 100 MG Oral Capsule | SY | 1b2f2afd-1e8a-058c-e063-6294a90a24ff | 2 |
| 1115005 | docusate sodium 100 MG Oral Capsule | PSN | 09376e58-c50a-4eda-ab2a-b980a4b65dc0 | 1 |
| 1115005 | docusate sodium 100 MG Oral Capsule | SCD | 09376e58-c50a-4eda-ab2a-b980a4b65dc0 | 1 |
| 1115005 | DOSS Sodium 100 MG Oral Capsule | SY | 09376e58-c50a-4eda-ab2a-b980a4b65dc0 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 16103-399-08 | 16103039908 | 100 CAPSULE in 1 BOTTLE (16103-399-08) | 100 capsule | 2016-03-01 | 0000-00-00 | No | No | Current |
| 16103-399-11 | 16103039911 | 1000 CAPSULE in 1 BOTTLE (16103-399-11) | 1000 capsule | 2016-03-01 | 0000-00-00 | No | No | Current |